CompanyDrug

Luye Pharma’s Lurbinectedin for Metastatic SCLC Wins Macau Regulatory Nod

CompanyDrug

Yantai Dongcheng Pharmaceutical Gets NMPA Green Light for FAP-Targeting Radiotherapeutic Drug

CompanyDrug

Tonghua Dongbao Pharmaceuticals Secures NMPA Approval for Biosimilar Liraglutide

CompanyDrug

Simcere Pharmaceutical’s SIM0501 Receives FDA Approval for Advanced Solid Tumor Clinical Trial

Company

WuXi Biologics Shares Plunge 22% on Slower CDMO Industry Growth and Revenue Shortfall

CompanyDeals

Abbisko Therapeutics Strikes Licensing Deal with Merck KGaA for CSF-1R Inhibitor Pimicotinib

CompanyDeals

Boehringer Ingelheim Partners with Shanghai Handu Pharma to Enhance Oral Medication Delivery

CompanyDeals

Gedeon Richter Acquires Rights to Mithra’s Contraceptive and Menopause Treatments for Chinese Market

CompanyDeals

Aspen Pharmacare Holdings to Boost China Presence with Full Acquisition of Sandoz’s Subsidiary

CompanyDrug

AstraZeneca Halts Late-Stage Trials for Lokelma in Hyperkalemia Due to Timing and Event Rate Issues

CompanyDeals

Roche Expands Beyond Oncology with USD 2.7 Billion Carmot Therapeutics Acquisition

CompanyDrug

Stem-Cell Startup Xellsmart Earns FDA Orphan Drug Designation for ALS Therapy